Batra Hospital and Medical Research Center, Delhi

Artificial intelligence (AI) is the ability of a computer to carry out tasks associated with intelligent beings. Very simply, it means that a computer is functioning and behaving like the human brain, and now possesses intellectual processes characteristic of humans, such as the ability to reason, discover meaning, generalize, logic, or learn from past experiences, and self-correction. Since the development of the digital computer in the 1940s, it has been demonstrated that computers can be programmed to carry out complex tasks   which require human-like cognitive ability like solving mathematical theorems or playing chess with great proficiency. Now due to continuing advances in computer processing and memory capacity, they are, to some extent, able to match human flexibility. It is logical to deduce that AI will revolutionize medicine and healthcare, but this will happen only if AI is available to the average, mainstream users – and not o...

Link to the original article Dr Upendra Kaul, Chairman Cardiology BHMRC co-chairs a path breaking study  In the first randomized trial of an Indian-made stent versus the best-in-class Xience stent (Abbott) conducted in Europe, the Supraflex sirolimus-eluting stent (SMT; Surat, India) proved itself to be a worthy competitor in results presented here at TCT 2018. In the TALENT trial, the rate of a device-oriented composite endpoint of cardiac death, target-vessel MI, and clinically indicated TLR at 12 months was 4.9% with Supraflex and 5.3% with Xience, a difference that met criteria for noninferiority ( P < 0.001), study chair Patrick Serruys, MD, PhD (Imperial College London, England, and Erasmus University, Rotterdam, the Netherlands), reported. Though there were no significant differences between groups for any of the components of the composite outcome, a per-protocol analysis suggested that TLR might be lower with Supraflex, which is not available in the ...